Rationale and Design of BeatNF2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Bevacizumab in Patients with Neurofibromatosis Type 2 Related Vestibular Schwannoma

SIMPLE SUMMARY: Neurofibromatosis type 2 (NF2) is a rare genetic hereditary disease characterized by multiple central nervous system tumors, most frequently bilateral vestibular schwannomas (VSs). No chemotherapeutic agents are available for clinical use, and surgery and radiotherapy are the only th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Masazumi, Kobayakawa, Masao, Saito, Kiyoshi, Inano, Akihiro, Morita, Akio, Hasegawa, Mitsuhiro, Mukasa, Akitake, Mitsuhara, Takafumi, Goto, Takeo, Yamaguchi, Shigeru, Tamiya, Takashi, Nakatomi, Hirofumi, Oya, Soichi, Takahashi, Fumiaki, Sato, Taku, Bakhit, Mudathir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985777/
https://www.ncbi.nlm.nih.gov/pubmed/33572546
http://dx.doi.org/10.3390/curroncol28010071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985777/
https://www.ncbi.nlm.nih.gov/pubmed/33572546
http://dx.doi.org/10.3390/curroncol28010071

Ejemplares similares